Latest filing published 29 Jul 2014 for Lemaitre Vascular INC, €1,290.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +77.2%Entry US$3.16 · Close at T+365 US$5.60
- -14.3%Entry US$3.29 · Close at T+365 US$2.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Linden V: trading record in brief
All filings by Robert Linden V on record concern Lemaitre Vascular Inc. The record holds 36 filings, for trades running from 25 April 2008 to 27 July 2014.
In open-market terms, that means 2 purchases worth €2,622 on one side and 3 sales worth €102k on the other. Taken together, the sales exceed the purchases by €99k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 30 share grants and 1 option exercise.
The newest entry dates from 29 July 2014: a share grant of €1,290, in Lemaitre Vascular Inc. The most recent open-market purchase was published on 29 May 2009, 6,373 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Linden V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 223 shares@ US$7.77Common StockSEC:0001181431-14-027650:0
- 340 shares@ US$6.94Common StockSEC:0001181431-13-047650:0
- 223 shares@ US$6.77Common StockSEC:0001181431-13-041871:0
- 9,383 shares@ US$6.45Common StockSEC:0001181431-13-033602:0
- 5,000 shares@ US$6.08Common StockSEC:0001181431-13-026259:0
- 6,941 shares@ US$6.11Common StockSEC:0001181431-13-026259:1
- 1,462 shares@ US$6.05Common StockSEC:0001181431-13-023748:0
- 338 shares@ US$6.07Common StockSEC:0001181431-12-048757:0
- 209 shares@ US$6.18Common StockSEC:0001181431-12-042600:0
- 31 shares@ US$6.29Common StockSEC:0001181431-12-041567:0
- 144 shares@ US$5.35Common StockSEC:0001181431-12-033104:0
- 1,650 shares@ US$5.42Common StockSEC:0001181431-12-025987:0
- 322 shares@ US$6.77Common StockSEC:0001181431-11-048198:0
- 30 shares@ US$7.44Common StockSEC:0001181431-11-042921:0
- 209 shares@ US$7.06Common StockSEC:0001181431-11-042921:1
- 157 shares@ US$7.02Common StockSEC:0001181431-11-026553:0
- 1,431 shares@ US$6.51Common StockSEC:0001181431-11-025552:0
- 754 shares@ US$3.00Common StockSEC:0001181431-10-046894:0
- 320 shares@ US$6.99Common StockSEC:0001181431-10-045509:0
- 207 shares@ US$5.83Common StockSEC:0001181431-10-038946:0
- 29 shares@ US$5.27Common StockSEC:0001181431-10-038049:0
- 137 shares@ US$4.94Common StockSEC:0001181431-10-024304:0
- 1,377 shares@ US$4.84Common StockSEC:0001181431-10-023220:0
- 148 shares@ US$4.90Common StockSEC:0001181431-09-058562:0
- 320 shares@ US$3.40Common StockSEC:0001181431-09-042763:0
25 of 36 declarations
